|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
US4444784A
(en)
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
ZA81703B
(en)
|
1980-02-04 |
1982-09-29 |
Merck & Co Inc |
New antihypercholesterolemic compounds,intermediates and processes
|
|
JPS572240A
(en)
|
1980-06-06 |
1982-01-07 |
Sankyo Co Ltd |
Ml-236b derivative
|
|
DK149080C
(da)
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
|
JPS60500015A
(ja)
|
1982-11-22 |
1985-01-10 |
サンド・アクチエンゲゼルシヤフト |
メバロラクトン同族体とその誘導体、これらの製造法およびこれらを含有する製薬学的組成物
|
|
US4739073A
(en)
|
1983-11-04 |
1988-04-19 |
Sandoz Pharmaceuticals Corp. |
Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
|
|
US5854259A
(en)
|
1987-08-20 |
1998-12-29 |
Nissan Chemical Industries Ltd. |
Quinoline type mevalonolactones
|
|
JP2569746B2
(ja)
|
1987-08-20 |
1997-01-08 |
日産化学工業株式会社 |
キノリン系メバロノラクトン類
|
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
|
JP2648897B2
(ja)
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
|
FR2688138B1
(fr)
|
1992-03-06 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
|
|
US7011828B2
(en)
|
2000-03-14 |
2006-03-14 |
Es Cell International Pte. Ltd. |
Implanting neural progenitor cells derived for human embryonic stem cells
|
|
WO2001088100A1
(en)
|
2000-05-16 |
2001-11-22 |
Kyowa Hakko Kogyo Co., Ltd. |
Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
|
|
US20060281179A1
(en)
|
2001-11-15 |
2006-12-14 |
Yoshiki Sasai |
Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
|
|
AU2003260618A1
(en)
*
|
2002-06-24 |
2004-01-06 |
Exonhit Therapeutics Sa |
Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
|
|
US20050202488A1
(en)
*
|
2004-03-02 |
2005-09-15 |
The General Hospital Corporation |
Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) gene
|
|
WO2005123902A1
(ja)
|
2004-06-18 |
2005-12-29 |
Riken |
無血清浮遊培養による胚性幹細胞の神経分化誘導法
|
|
WO2006105806A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Miso Sabovic |
Delaying the ageing process and disorders caused by ageing
|
|
US20060252775A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Henderson Samuel T |
Methods for reducing levels of disease associated proteins
|
|
US7977314B2
(en)
*
|
2005-12-02 |
2011-07-12 |
Amorfix Life Sciences Limited |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
US8048999B2
(en)
|
2005-12-13 |
2011-11-01 |
Kyoto University |
Nuclear reprogramming factor
|
|
JP5813321B2
(ja)
|
2007-03-23 |
2015-11-17 |
ウィスコンシン アラムニ リサーチ ファンデーション |
体細胞の再プログラム化
|
|
WO2008127974A1
(en)
*
|
2007-04-13 |
2008-10-23 |
The Trustees Of Columbia University In The City Of New York |
Stem cell-based culture system for drug development
|
|
JP2009215191A
(ja)
*
|
2008-03-07 |
2009-09-24 |
Keio Gijuku |
神経損傷治療剤及び神経損傷治療方法
|
|
WO2009146098A2
(en)
*
|
2008-04-02 |
2009-12-03 |
President And Fellows Of Harvard College |
Stem cells and uses thereof
|